Loading clinical trials...
Loading clinical trials...
The purpose of this study is to assess the safety, drug levels and effects on the body of 1 or 3 injections of MEDI1814, in people with mild to moderate Alzhiemer's Disease or healthy elderly people.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
AstraZeneca
NCT07077460 · Healthy Elderly
NCT04795284 · Lumbar Spinal Stenosis, Healthy Elderly
NCT03818802 · Healthy Elderly Volunteers
NCT06801782 · Parkinson's Disease with Cognitive Impairment, Healthy Elderly
NCT06435078 · Healthy Elderly, Alzheimer Disease
Research Site
Glendale, California
Research Site
Long Beach, California
Research Site
Panorama City, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions